• Patient Site
  • V-Go Customer Care
vgo green
  • Call 1-866-881-1209
  • Sign Up for Updates
  • About V-Go
    • What is V-Go®?
    • Who is it For?
    • How it Works
    • Why V-Go®?
  • Clinical Data
    • Optimize Delivery
    • Efficacy
    • Insulin Reduction
    • Patient Adherence
  • Prescribing & Dosing
    • Overview
  • Patient Support
    • Starting Patients
    • Comprehensive Support for You and Your Patients
    • Common Patient Questions
  • Coverage & Savings
    • Overview
  • Pharmacists
    • Overview
    • Reimbursement Card

Give Your Patients What They Need for Less

We’ve Got You Covered

As your patients start a new therapy, reimbursement may be a concern. To help them get over this potential hurdle, Valeritas proudly provides expert, personalized insurance guidance and a variety of resources for your patients.

Medicare
V-Go® is covered by law as a Part D benefit.

According to CMS:

  • Disposable insulin delivery devices are covered under the Medicare Part D pharmacy benefit.*
    *Section 1860D-2(e) of the Social Security Act.
Female v-go patient

V-Go Cost Savings Card

With the V-Go Cost Savings Card, commercially insured patients pay $0 for their first prescription at any retail pharmacy.† Refills cost $75 or less depending on their insurance benefit.

V-Go cost savings card

Here’s what your patients need to do to start saving.

  • Simply download and print the card (cards have no expiration date§).
  • Activate it by calling the toll-free number on the card.
  • Present the card to their pharmacist for savings.
  • Start saving!

Download Card

†30-day supply.
§30-day public notice of cancellation. This card is NOT valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other similar federal or state healthcare program, including any state pharmacy assistance program. This card is only valid for insured patients.

V-Gp copay card

Notice of Expiration

The terms of the previously available V-Go Co-pay Reduction Card, which was effective November 1, 2015 will no longer apply starting September 1, 2018.

Under the V-Go Co-pay Program, commercially-insured patients pay $0 for their first prescription and $75 or less, depending on insurance benefit. See details above.

If you have any questions, please contact V-Go Customer Care at 1-866-881-1209.

With less insulin and fewer co-pays than MDI, V-Go gives your patients more of what they need for less

  • Covered under Medicare Part D
  • 100% of commercially insured patients are covered by plan and/or V-Go Cost Savings Card
  • >95% of prescriptions are filled at retail pharmacies
  • Fewer co-pays1
  • Less insulin2

V-Go vs. MDI chart

V-Go demonstrated substantial savings over MDI

$146 less in direct pharmacy costs per month

A real-world study, evaluating 86 patients switched from MDI to V-Go, showed significant (P=0.001) savings in direct pharmacy costs per patient per month.2,*†‡

Cost savings realized by the plan can be passed down to patients in the form of lower premiums and lower co-pays.

Download the Cost Savings Card

Man on cell phone
Customer Care image

V-Go Customer Care provides comprehensive reimbursement support for you and your patients

  • Coverage and cost determination
  • Coverage card activation
  • Pharmacy fulfillment support
Fax machine iconFax 1-866-729-4670
Telephone icon Call 1-866-881-1209
Computer screen icon Go to V-Go Customer Care
*Average cost inclusive of V-Go and pen needles for patients administering supplemental insulin.
†Data are means and rounded to the dollar.
‡Average monthly costs are normalized to 30 days and based on calculated costs for basal and/or prandial units/day based on average market leaders unit pricing. MDI pen needles and/or syringes (4 per day) based on market leader average unit pricing. Concomitant antihyperglycemic non-insulin agents not included.
V-Go Cost Savings Card
Speak to a V-Go Partner Today

Reach out to V-Go Customer Care today at 1-866-881-1209 to speak to a V-Go Partner about any questions regarding the V-Go Cost Savings Card.

Download Card
V-Go copay card image

References: 1. Sutton D, Higdon C, Carmon M, Martinez J, Peasah S. Evaluating cost of therapy and clinical efficacy with V-Go in patients with sub-optimally controlled diabetes from an endocrine specialty system. Presented at the Academy of Managed Care Pharmacy Annual Meeting, San Francisco, CA. April 2016. [Poster] 2. Lajara R, Nikkel C. Evaluation of real-world clinical and pharmacy budget outcomes when switching to a wearable insulin delivery device for insulin administration in patients with sub-optimally controlled diabetes. Presented at: ISPOR 22nd Annual International Meeting, Boston MA. May 2017 [Poster]

Important Risk Information

If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.

  • Product Specs
  • Important Safety Information
  • Contact Us
  • Valeritas.com
  • Valeritas Newsroom
  • Terms of Use & Privacy
  • Cookies
  • Site Map
  • Twitter
  • YouTube
Valeritas logo
White V-Go® logo
© 2019 Valeritas Inc
Sign up for Updates About V-Go
Schedule a Live Demo
This website uses cookies to improve your browsing experience. Read MoreAccept
Cookies Policy

Necessary Always Enabled